Thank you for that question. We do a huge number of things in those areas. I was here to speak to you specifically on the health sector area, about which I am better versed, so I may have to get you further information in terms of the other sectors, like environment, transport, and infrastructure. Some of those are areas that CIDA is not as invested in as we are particularly in the health sector. The health sector is our largest single sector.
That said, all those things do relate, as I mentioned, in terms of the challenges for developing countries. I was just outlining a few of them. But the important message to take home is that these are things that are being overcome. It was just a few years ago that if someone came before your committee and talked about HIV and AIDS treatment, you'd hear challenges that there's almost nobody receiving HIV and AIDS treatment in Africa. The numbers were really quite small. Now we're seeing in Africa well over a million people receiving HIV/AIDS treatment. That's due to innovative ways of delivering medicine, to strengthening health systems, to donors putting in more money, and to developing countries themselves putting in more money and investing in health systems and ensuring nutrition and safe water.
Those are challenges that have not gone away, but we have seen, really, some good successes, and Canada has certainly been quite involved in them. In that timeframe, the global fund, which I mentioned before, has put huge amounts of resources into HIV/AIDS health, malaria, and tuberculosis.
All of those, absolutely, relate specifically to CAMR in terms of creating the conditions within which developing countries can deliver the medicines. CAMR is a very specific initiative in terms of, hopefully, creating greater availability and more options for developing countries to access medicines and making Canadian suppliers, through compulsory licensing, able to do that. So there are many options, and greater options, through which developing countries can access the medicines.
That's very specific to the purchase and availability of affordable medicines. But you're right. There's a much bigger picture around all that in which Canada is very heavily invested and where it has had some very good successes. We continue to invest in those, and we'll continue to do more.